Treatment of high-risk gestational trophoblastic tumors

Clinical Obstetrics and Gynecology

Volumn 46, Issue 3, 2003, Pages 593-606

  Wright, Jason D ^a   Mutch, David G ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CHLORAMBUCIL; CHORIONIC GONADOTROPIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; FLUOROURACIL; FOLLITROPIN; IFOSFAMIDE; LUTEINIZING HORMONE; METHOTREXATE; PACLITAXEL; VINCRISTINE;

ALOPECIA; ANEMIA; BLOOD TOXICITY; BLOOD TRANSFUSION; BONE MARROW SUPPRESSION; BRAIN METASTASIS; BREAST CANCER; CANCER CLASSIFICATION; CANCER STAGING; CLINICAL FEATURE; COLON CANCER; CONFERENCE PAPER; CONTINUOUS INFUSION; DRUG DOSE REGIMEN; FEMALE; HIGH RISK POPULATION; HUMAN; HYSTERECTOMY; LEUKOPENIA; LIVER HEMORRHAGE; LIVER METASTASIS; LUNG METASTASIS; MYELOID LEUKEMIA; NEUTROPENIA; RELAPSE; SECOND CANCER; SEPSIS; THROMBOCYTOPENIA; TROPHOBLASTIC TUMOR; VISCERAL METASTASIS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; GESTATIONAL TROPHOBLASTIC NEOPLASMS; HUMANS; NEOPLASM METASTASIS; NEOPLASM STAGING; PREGNANCY; SALVAGE THERAPY; SURVIVAL RATE; UTERINE NEOPLASMS;

EID: 0141675163     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200309000-00010     Document Type: Conference Paper

References (76)

1. Li MC HR, Spencer DB. Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma. Proc Soc Exp Biol Med. 1956;93:361-366.
2. Lurain JR. Advances in management of high-risk gestational trophoblastic tumors. Reprod Med. 2002;47:451-459.
3. Brewer JI, Eckman TR, Dolkart RE, et al. Gestational trophoblastic disease. A comparative study of the results of therapy in patients with invasive mole and with choriocarcinoma. Am J Obstet Gynecol. 1971;109:335-340.
4. Hertz R JJ, Lipsett MD. Five years' experience with the chemotherapy of metastatic choriocarcinoma and related trophoblastic tumors in women. Am J Obstet Gynecol. 1961;82:631-640.
5. Hammond CB, Borchert LG, Tyrey L, et al. Treatment of metastatic trophoblastic disease: good and poor prognosis. Am J Obstet Gynecol. 1973;115:451-457.
6. Hammond CB, Weed JC Jr, Currie JL. The role of operation in the current therapy of gestational trophoblastic disease. Am J Obstet Gynecol. 1980;136:844-858.
7. Miller JM Jr, Surwit EA, Hammond CB. Choriocarcinoma following term pregnancy. Obstet Gynecol. 1979;53:207-212.
8. Lurain JR, Casanova LA, Miller DS, et al. Prognostic factors in gestational trophoblastic tumors: a proposed new scoring system based on multivariate analysis. Am J Obstet Gynecol. 1991;164:611-616.
9. Bagshawe KD. Risk and prognostic factors in trophoblastic neoplasia. Cancer. 1976;38:1373-1385.
10. World Health Organization Scientific Group. Gestational trophoblastic disease. Technical report series 692. Geneva, Switzerland: World Health Organization, 1983.
11. Soper JT, Evans AC, Conaway MR, et al. Evaluation of prognostic factors and staging in gestational trophoblastic tumor. Obstet Gynecol. 1994;84:969-973.
12. Pettersson F KP. Ludwig H, et al, es. Annual report on the results of treatment in gynecologic cancer. Vol. 19. Stockholm: International Federation of Gynecology and Obstetrics, 1985.
13. Lurain JR, Brewer JI, Torok EE, et al. Gestational trophoblastic disease: treatment results at the Brewer Trophoblastic Disease Center. Obstet Gynecol. 1982;60:354-360.
14. Kendall A, Gillmore R, Newlands E. Chemotherapy for trophoblastic disease: current standards. Curr Opin Obstet Gynecol. 2002;14:33-38.
15. Dubuc-Lissoir J, Sweizig S, Schlaerth JB, et al. Metastatic gestational trophoblastic disease: a comparison of prognostic classification systems. Gynecol Oncol. 1992;45:40-45.
16. Berkowitz RS, Goldstein DP, Bernstein MR. Modified triple chemotherapy in the management of high-risk metastatic gestational trophoblastic tumors. Gynecol Oncol. 1984;19:173-181.
17. Surwit EA, Hammond CB. Treatment of metastatic trophoblastic disease with poor prognosis. Obstet Gynecol. 1980;55:565-570.
18. Gordon AN, Gershenson DM, Copeland LJ, et al. High-risk metastatic gestational trophoblastic disease. Obstet Gynecol. 1985;65:550-556.
19. Lurain JR, Brewer JI. Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy. Obstet Gynecol. 1985;65:830-836.
20. Curry SL, Blessing JA, DiSaia PJ, et al. A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in "poor prognosis" metastatic gestational trophoblastic disease: a Gynecologic Oncology Group study. Obstet Gynecol. 1989;73:357-362.
21. Bagshawe KD. Treatment of high-risk choriocarcinoma. J Reprod Med. 1984;29:813-820.
22. Weed JC Jr, Barnard DE, Currie JL, et al. Chemotherapy with the modified Bagshawe protocol for poor prognosis metastatic trophoblastic disease. Obstet Gynecol. 1982;59:377-380.
23. Wong LC, Choo YC, Ma HK. Modified Bagshawe's regimen in high-risk gestational trophoblastic disease. Gynecol Oncol. 1986;23:87-93.
24. Newlands ES, Bagshawe KD, Begent RH, et al. Developments in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumours (1979-1984). Br J Obstet Gynaecol. 1986;93:63-69.
25. Newlands ES, Bagshawe KD, Begent RH, et al. Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989. Br J Obstet Gynaecol. 1991;98:550-557.
26. Bower M, Newlands ES, Holden L, et al. EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. J Clin Oncol. 1997;15:2636-2643.
27. Soper JT, Evans AC, Clarke-Pearson DL, et al. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease. Obstet Gynecol. 1994;83:113-117.
28. Schink JC, Singh DK, Rademaker AW, et al. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease. Obstet Gynecol. 1992;80:817-820.
29. Kim SJ, Bae SN, Kim JH, et al. Risk factors for the prediction of treatment failure in gestational trophoblastic tumors treated with EMA/CO regimen. Gynecol Oncol. 1998;71:247-253.
30. Soto-Wright V, Goldstein DP, Bernstein MR, et al. The management of gestational trophoblastic tumors with etoposide, methotrexate, and actinomycin D. Gynecol Oncol. 1997;64:156-159.
31. Matsui H, Suzuka K, Iitsuka Y, et al. Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors. Gynecol Oncol. 2000;78:28-31.
32. Theodore C, Azab M, Droz JP, et al. Treatment of high-risk gestational trophoblastic disease with chemotherapy combinations containing cisplatin and etoposide. Cancer. 1989;64:1824-1828.
33. Bakri YN, Subhi J, Amer M, et al. Liver metastases of gestational trophoblastic tumor. Gynecol Oncol. 1993;48:110-113.
34. Bakri Y, Berkowitz RS, Goldstein DP, et al. Brain metastases of gestational trophoblastic tumor. J Reprod Med. 1994;39:179-184.
35. Surwit EA, Childers JM. High-risk metastatic gestational trophoblastic disease. A new dose-intensive, multiagent chemotherapeutic regimen. J Reprod Med. 1991;36:45-48.
36. Hartenbach EM, Saltzman AK, Carter JR, et al. A novel strategy using G-CSF to support EMA/CO for high-risk gestational trophoblastic disease. Gynecol Oncol. 1995;56:105-108.
37. Okamoto T, Nawa A, Nakanishi T, et al. Usefulness of granulocyte colony-stimulating factor on neutropenia in patients of invasive mole and choriocarcinoma. Oncology. 1995;52:159-162.
38. Rustin GJ, Newlands ES, Lutz JM, et al. Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors. J Clin Oncol. 1996;14:2769-2773.
39. Ratain MJ, Kaminer LS, Bitran JD, et al. Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung. Blood. 1987;70:1412-1417.
40. Whitlock JA, Greer JP, Lukens JN. Epipodophyllotoxin-related leukemia. Identification of a new subset of secondary leukemia. Cancer. 1991;68:600-604.
41. Boshoff C, Begent RH, Oliver RT, et al. Secondary tumours following etoposide containing therapy for germ cell cancer. Ann Oncol. 1995;6:35-40.
42. Pedersen-Bjergaard J, Daugaard G, Hansen SW, et al. Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours. Lancet. 1991;338:359-363.
43. Pui CH, Ribeiro RC, Hancock ML, et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med. 1991;325:1682-1687.
44. Mutch DG, Soper JT, Babcock CJ, et al. Recurrent gestational trophoblastic disease. Experience of the Southeastern Regional Trophoblastic Disease Center. Cancer. 1990;66:978-982.
45. Newlands ES, Mulholland PJ, Holden L, et al. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. J Clin Oncol. 2000;18:854-859.
46. Soper JT, Evans AC, Rodriguez G, et al. Etoposide-platin combination therapy for chemorefractory gestational trophoblastic disease. Gynecol Oncol. 1995;56:421-424.
47. Schlaerth JB, Morrow CP, DePetrillo AD. Sustained remission of choriocarcinoma with cis-platinum, vinblastine, and bleomycin after failure of conventional combination drug therapy. Am J Obstet Gynecol. 1980;136:983-985.
48. Gordon AN, Kavanagh JJ, Gershenson DM, et al. Cisplatin, vinblastine, and bleomycin combination therapy in resistant gestational trophoblastic disease. Cancer. 1986;58:1407-1410.
49. DuBeshter B, Berkowitz RS, Goldstein DP, et al. Vinblastine, cisplatin and bleomycin as salvage therapy for refractory high-risk metastatic gestational trophoblastic disease. J Reprod Med. 1989;34:189-192.
50. Azab M, Droz JP, Theodore C, et al. Cisplatin, vinblastine, and bleomycin combination in the treatment of resistant high-risk gestational trophoblastic tumors. Cancer. 1989;64:1829-1832.
51. Surwit EA, Alberts DS, Christian CD, et al. Poor-prognosis gestational trophoblastic disease: an update. Obstet Gynecol. 1984;64:21-26.
52. Willemse PH, Aalders JG, Bouma J, et al. Chemotherapy-resistant gestational trophoblastic neoplasia treated successfully with cisplatin, etoposide, and bleomycin. Obstet Gynecol. 1988;71:438-440.
53. Wong LC, Choo YC, Ma HK. Etoposide, methotrexate, and bleomycin in drug-resistant gestational trophoblastic disease. Gynecol Oncol. 1986;24:51-57.
54. Chen LP, Cai SM, Fan JX, et al. PEBA regimen (cisplatin, etoposide, bleomycin, and adriamycin) in the treatment of drug-resistant choriocarcinoma. Gynecol Oncol. 1995;56:231-234.
55. Sutton GP, Soper JT, Blessing JA, et al. Ifosfamide alone and in combination in the treatment of refractory malignant gestational trophoblastic disease. Am J Obstet Gynecol. 1992;167:489-495.
56. Garris PD, Gallup DG, Melton K. Long-term remission of previously resistant choriocarcinoma with a combination of etoposide, ifosfamide, and cisplatin. Gynecol Oncol. 1995;57:254-256.
57. Jones WB, Schneider J, Shapiro F, et al. Treatment of resistant gestational choriocarcinoma with taxol: a report of two cases. Gynecol Oncol. 1996;61:126-130.
58. Termrungruanglert W, Kudelka AP, Piamsomboon S, et al. Remission of refractory gestational trophoblastic disease with high-dose paclitaxel. Anticancer Drugs. 1996;7:503-506.
59. Matsui H, Suzuka K, Iitsuka Y, et al. Salvage combination chemotherapy with 5-fluorouracil and actinomycin D for patients with refractory, high-risk gestational trophoblastic tumors. Cancer. 2002;95:1051-1054.
60. Collins RH Jr, White CS, Stringer CA, et al. Successful treatment of refractory gestational trophoblastic neoplasm with high-dose etoposide and cyclophosphamide. Gynecol Oncol. 1991;43:317-319.
61. Giacalone PL, Benos P, Donnadio D, et al. High-dose chemotherapy with autologous bone marrow transplantation for refractory metastatic gestational trophoblastic disease. Gynecol Oncol. 1995;58:383-385.
62. Lotz JP, Andre T, Donsimoni R, et al. High-dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults. Cancer. 1995;75:874-885.
63. Evans AC Jr, Soper JT, Clarke-Pearson DL, et al. Gestational trophoblastic disease metastatic to the central nervous system. Gynecol Oncol. 1995;59:226-230.
64. Yordan EL Jr, Schlaerth J, Gaddis O, et al. Radiation therapy in the management of gestational choriocarcinoma metastatic to the central nervous system. Obstet Gynecol. 1987;69:627-630.
65. Athanassiou A, Begent RH, Newlands ES, et al. Central nervous system metastases of choriocarcinoma. 23 years' experience at Charing Cross Hospital. Cancer. 1983;52:1728-1735.
66. Rustin GJ, Newlands ES, Begent RH, et al. Weekly alternating etoposide, methotrexate, and actinomycin/vincristine and cyclophosphamide chemotherapy for the treatment of CNS metastases of choriocarcinoma. J Clin Oncol. 1989;7:900-903.
67. Small W Jr, Lurain JR, Shetty RM, et al. Gestational trophoblastic disease metastatic to the brain. Radiology. 1996;200:277-280.
68. Soper JT. Surgical therapy for gestational trophoblastic disease. J Reprod Med. 1994;39:168-174.
69. Lang EK. Reduced systemic toxicity from superselective chemoembolization compared with systemic chemotherapy in patients with high-risk metastatic gestational trophoblastic disease. Cardiovasc Intervent Radiol. 1997;20:280-284.
70. Grumbine FC, Rosenshein NB, Brereton HD, et al. Management of liver metastasis from gestational trophoblastic neoplasia. Am J Obstet Gynecol. 1980;137:959-961.
71. Saitoh K, Harada K, Nakayama H, et al. Role of thoracotomy in pulmonary metastases from gestational choriocarcinoma. J Thorac Cardiovasc Surg. 1983;85:815-820.
72. Tomoda Y, Arii Y, Kaseki S, et al. Surgical indications for resection in pulmonary metastasis of choriocarcinoma. Cancer. 1980;46:2723-2730.
73. Soper JT, Mutch DG, Chin N, et al. Renal metastases of gestational trophoblastic disease: a report of eight cases. Obstet Gynecol. 1988;72:796-798.
74. Cole LA. Phantom hCG and phantom choriocarcinoma. Gynecol Oncol. 1998;71:325-329.
75. Lurain JR, Brewer JI, Mazur MT, et al. Fatal gestational trophoblastic disease: an analysis of treatment failures. Am J Obstet Gynecol. 1982;144:391-395.
76. Mazur MT, Lurain JR, Brewer JI. Fatal gestational choriocarcinoma. Clinicopathologic study of patients treated at a trophoblastic disease center. Cancer. 1982;50:1833-1846.